CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 161 filers reported holding CYTOKINETICS INC in Q2 2020. The put-call ratio across all filers is 1.54 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $408,934 | -59.3% | 13,881 | -55.0% | 0.00% | -66.7% |
| Q2 2023 | $1,005,249 | +4.1% | 30,817 | +12.3% | 0.01% | 0.0% |
| Q1 2023 | $965,402 | -62.9% | 27,434 | -51.8% | 0.01% | -59.1% |
| Q4 2022 | $2,605,371 | -16.4% | 56,861 | -28.4% | 0.02% | -26.7% |
| Q2 2022 | $3,118,000 | +932.5% | 79,366 | +867.9% | 0.03% | +900.0% |
| Q1 2022 | $302,000 | -93.5% | 8,200 | -91.9% | 0.00% | -92.9% |
| Q4 2021 | $4,635,000 | +63.1% | 101,700 | +27.9% | 0.04% | +44.8% |
| Q3 2021 | $2,841,000 | +606.7% | 79,516 | +291.7% | 0.03% | +625.0% |
| Q2 2021 | $402,000 | +157.7% | 20,300 | +53.1% | 0.00% | -60.0% |
| Q1 2020 | $156,000 | -15.2% | 13,263 | -33.7% | 0.01% | -67.7% |
| Q3 2016 | $184,000 | – | 20,000 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 223,382 | $6,580,834 | 7.72% |
| Finepoint Capital LP | 431,693 | $12,717,676 | 6.33% |
| Saturn V Capital Management LP | 495,168 | $14,587,649 | 6.11% |
| Logos Global Management LP | 1,250,000 | $36,825,000 | 4.91% |
| DAFNA Capital Management LLC | 479,538 | $14,127,189 | 4.39% |
| PFM Health Sciences, LP | 2,399,545 | $70,690,596 | 3.33% |
| Boxer Capital, LLC | 2,100,000 | $61,866,000 | 3.29% |
| Integral Health Asset Management, LLC | 800,000 | $23,568,000 | 3.26% |
| GREAT POINT PARTNERS LLC | 600,000 | $17,676,000 | 3.22% |
| Nicholas Investment Partners, LP | 942,137 | $27,755,356 | 2.07% |